Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 7/20 | 0.51 |
| ▸ | CALCR | P30988 | 7/20 | 0.51 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.48 |
| ▸ | CTSL | P07711 | 3/20 | 0.46 |
| ▸ | CTSS | P25774 | 3/20 | 0.46 |
| ▸ | CTSK | P43235 | 3/20 | 0.46 |
| ▸ | CTSH | P09668 | 1/20 | 0.46 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437169 | 0.95 | OPRM1 (0.52) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL31437175 | 0.95 | OPRM1 (0.49) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL31416058 | 0.89 | RAMP3 (0.52) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL31186832 | 0.89 | EPHA2 (0.50) | RAMP3CALCREPHA2 | |
| SCHEMBL31416061 | 0.88 | RAMP3 (0.51) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL32677400 | 0.87 | CXCR4 (0.47) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL32677398 | 0.87 | CXCR4 (0.47) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL32677417 | 0.87 | CXCR4 (0.47) | RAMP3CALCREPHA2OPRM1OPRK1 | |
| SCHEMBL7789924 | 0.86 | OPRM1 (0.48) | EPHA2OPRM1OPRK1CXCR4 | |
| SCHEMBL31437212 | 0.86 | RAMP3 (0.50) | RAMP3CALCREPHA2OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | claimed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |